Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
SYSTOLIC VERSUS DIASTOLIC FAILURE
Multiple studies across countries have now shown that the long-term prognosis of diastolic heart failure is not very different from that of systolic heart failure.1–3 If that is the case then why bother differentiating between the two types of heart failure? The answer is because the treatment options differ greatly between the two conditions. Whereas treatment (drug and device) is well characterised for systolic dysfunction,4 there are precious few data and options available for treating diastolic dysfunction.4 While ejection fractions and left ventricular cavity size differ between the two forms of heart failure, signs and symptoms and neurohumoral abnormalities are similar between the two. These have been elegantly summarised recently by Chatterjee and Massie5 (table 1). It has even been proposed that these two forms of heart failure may be different phenotypes of the same pathophysiological basis.6 The stimuli responsible for these phenotypic differences are largely unknown.5–7
Despite advances in treatment for congestive heart failure (CHF), mortality remains 40–80% higher for diabetic subjects with CHF than for non-diabetic subjects.8 Diabetes prevalence is increasing world wide, with prevalence of diabetes among patients with CHF increasing at an even faster pace.9 A recent report based on a nationwide registry in the United States showed that 44% of patients with CHF have diabetes.10 Diabetes has a particularly pernicious effect among women for the development of CHF.11 While multiple mechanisms are responsible for development of CHF in diabetes, ischaemic heart disease and comorbidities such as obesity and hypertension play a major role. …
Competing interests: None.